Autopsy report · NCT01335204
Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer
Cause of deathFunding or business
“lack of funding”
Life of this trial
- Registered 2 months before it started.
- Ran for about 1 year 9 months before it stopped.
- 4 participants enrolled.
- Results were posted on the registry 5 years 4 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Medical University of South Carolina
- Sponsor type
- University, hospital or other
- Conditions
- Prostate Cancer; Prostatic Neoplasms
- Interventions
- Cabazitaxel plus bavituximab
- Participants
- 4
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.